Showing results (11-20 of 69) with videos related to
Sort By:
Pageof 7
NEJM Evidence|August 27, 2024
The Case for Access to Data Monitoring Committee ChartersDeborah Zarin, Janet T Wittes, Thomas R Fleming, et al.Clinical Trials (London, England)|May 26, 2023
Bringing data monitoring committee charters into the sunlightDavid L DeMets, Deborah A Zarin, Frank Rockhold, et al.Clinical Therapeutics|February 19, 2022
Real-World Evidence for Regulatory Decision-Making: Guidance From Around the WorldLeah Burns, Nadege Le Roux, Robert Kalesnik-Orszulak, et al.Frontiers in Medicine|November 29, 2023
Real-world evidence for regulatory decision-making: updated guidance from around the worldLeah Burns, Nadege Le Roux, Robert Kalesnik-Orszulak, et al.Journal of the American College of Cardiology|February 11, 2026
Extension Reports in Clinical Trials: A Systematic Review and Consequent GuidanceXavier Rossello, Stuart J Pocock, Dylan Taylor, et al.Journal of Cardiovascular Pharmacology and Therapeutics|October 13, 2010
A randomized trial of aspirin at clinically relevant doses and nitric oxide formation in humansCharles H Hennekens, Wendy R Schneider, Alex Pokov, et al.Contemporary Clinical Trials|July 6, 2010
Academic perspectives on the United States Food and Drug Administration's guidance for industry on diabetes mellitusCharles H Hennekens, Patricia R Hebert, Wendy R Schneider, et al.Annals of Internal Medicine|November 19, 2019
Presenting Risks and Benefits: Helping the Data Monitoring Committee Do Its JobScott R Evans, Robert Bigelow, Christy Chuang-Stein, et al.Journal of Cardiovascular Pharmacology and Therapeutics|March 26, 2013
Aspirin increases nitric oxide formation in chronic stable coronary diseaseScott Hetzel, David DeMets, Ricky Schneider, et al.Contemporary Clinical Trials|February 19, 2022
COVID-19 interventional trials: Analysis of data sharing intentions during a time of pandemicKristina Larson, Ida Sim, Megan von Isenburg, et al.Pageof 7